J. Messina

Acral melanoma: clinical advances and hope for the future.
20233 citationsauthor #2
Interobserver agreement in the histopathological classification of desmoplastic melanomas.
20236 citationsauthor #8
Fucosylation of HLA-DRB1 regulates CD4+ T cell-mediated anti-melanoma immunity and enhances immunotherapy efficacy
202340 citationsauthor #24
Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions: A Consensus Statement.
202352 citationsauthor #24
Circulating tumor DNA‐based molecular residual disease detection for treatment monitoring in advanced melanoma patients
202355 citationsauthor #15
Atypical Fibroxanthoma: Outcomes from a Large Single Institution Series
202310 citationsauthor #11
Single cell characterization of the cellular landscape of acral melanoma identifies novel targets for immunotherapy.
202276 citationsauthor #16
ASO Visual Abstract: Is There a Relationship Between Tumor-Infiltrating Lymphocytes (TILs) and Regression in Melanoma?
20220 citationsauthor #11
Is the presence of tumor‐infiltrating lymphocytes predictive of outcomes in patients with melanoma?
20229 citationsauthor #12
617 Neoadjuvant intratumoral TAVO-EP (plasmid IL-12 electro gene transfer) in combination with nivolumab; preliminary clinical and biomarker data in patients with operable locoregionally advanced melanoma
20225 citationsauthor #17
LBA42 Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma
20220 citationsauthor #16
Is There a Relationship Between TILs and Regression in Melanoma?
202212 citationsauthor #11
Genomic and single-cell landscape reveals novel drivers and therapeutic vulnerabilities of transformed cutaneous T-cell lymphoma.
202224 citationsauthor #16
Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial.
202290 citationsauthor #32
Sentinel lymph node melanoma metastases: Assessment of tumor burden for clinical prediction of outcome in the first Multicenter Selective Lymphadenectomy Trial (MSLT-I).
20229 citationsauthor #50
Current and future approaches in the surgical management of T3b/T4 primary and locoregionally advanced melanoma
20221 citationsauthor #4
LB774 Comparison of clinical and pathologic assessment of lesions in Mycosis Fungoides
20210 citationsauthor #2
What's new in pediatric melanoma and Spitz tumors? Pretty much everything
20216 citationsauthor #2
Regression in melanoma is significantly associated with a lower regional recurrence rate and better recurrence‐free survival
20212 citationsauthor #9
Clinical characteristics and prognostic factors of 70 patients with Sézary syndrome: a single-institutional experience at Moffitt cancer center
20217 citationsauthor #14
Association between Human Polyomaviruses and Keratinocyte Carcinomas: A Prospective Cohort Study
20214 citationsauthor #3
Regression is significantly associated with outcomes for patients with melanoma.
202111 citationsauthor #9
Detection of cancer metastasis: past, present and future
202110 citationsauthor #6
The Role of External Genital Lesions in Human Immunodeficiency Virus Seroconversion Among Men Participating in a Multinational Study
20210 citationsauthor #6
Mapping Cutaneous T-Cell Lymphoma in the State of Florida - Supplemental
20210 citationsauthor #4
Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal Metastases
2021113 citationsauthor #8
Impact of Next-generation Sequencing on Interobserver Agreement and Diagnosis of Spitzoid Neoplasms
202121 citationsauthor #18
Cutaneous Human Papillomaviruses and the Risk of Keratinocyte Carcinomas
202118 citationsauthor #4
Mapping Cutaneous T-Cell Lymphoma in the State of Florida: a Retrospective Exploratory Spatial Analysis of Incidence Patterns.
20216 citationsauthor #3
Appropriate use criteria for ancillary diagnostic testing in dermatopathology: New recommendations for 11 tests and 220 clinical scenarios from the American Society of Dermatopathology Appropriate Use Criteria Committee
202113 citationsauthor #27
A Mutational Survey of Acral Nevi.
202118 citationsauthor #10
Circulating Immunosuppressive Regulatory T Cells Predict Risk of Incident Cutaneous Squamous Cell Carcinoma
20213 citationsauthor #2
Automated digital TIL analysis (ADTA) adds prognostic value to standard assessment of depth and ulceration in primary melanoma
202127 citationsauthor #23
OTME-17. Single cell characterization of the immune microenvironment of melanoma brain and leptomeningeal metastases
20211 citationsauthor #8
Noncanonical EphA2 Signaling Is a Driver of Tumor-Endothelial Cell Interactions and Metastatic Dissemination in BRAF InhibitorResistant Melanoma
20211 citationsauthor #6
Automated digital TIL analysis (ADTA) adds prognostic value to standard assessment of depth and ulceration in primary melanoma
20210 citationsauthor #23
LMD-03. Single cell analysis reveals how therapy remodels the tumor microenvironment in melanoma CNS metastases and uncovers a novel predictor of improved survival
20210 citationsauthor #8
Cost-Effective Patient Selection for Adjuvant Therapy in Stage IIIA Melanoma.
20201 citationsauthor #2
Cereblon Harnesses Myc-Dependent Bioenergetics and Activity of CD8+ T lymphocytes.
202017 citationsauthor #26
Cutaneous viral infections associated with ultraviolet radiation exposure
20205 citationsauthor #5
Correction to: Merkel Cell Carcinoma Outcomes: Does AJCC8 Underestimate Survival?
20201 citationsauthor #7
Neoadjuvant BRAF‐targeted therapy in regionally advanced and oligometastatic melanoma
202015 citationsauthor #13
Metabolomics of primary cutaneous melanoma and matched adjacent extratumoral microenvironment
202016 citationsauthor #10
Ipilimumab/nivolumab‐induced pseudolymphoma in a patient with malignant melanoma
20208 citationsauthor #5
Cutaneous squamous cell carcinoma causing a rhinophymatous mass in a patient with clinically occult hypertrophic lupus erythematosus
20205 citationsauthor #4
CD8‐positive cutaneous lymphoproliferation associated with large granular lymphocyte leukemia in a patient with X‐linked agammaglobulinemia
20207 citationsauthor #5
Abstract B41: BRAF targeting sensitizes resistant melanoma to cytotoxic T cells
20201 citationsauthor #8
Abstract A73: Fucosylation in CD4+ T cell-mediated melanoma suppression
20200 citationsauthor #7
Abstract 3492: Circulating immunosuppressive regulatory T cells and risk of incident cutaneous squamous cell carcinoma
20200 citationsauthor #4
Utility of flow cytometry and gene rearrangement analysis in tissue and blood of patients with suspected cutaneous T‑cell lymphoma.
202019 citationsauthor #10
Non-canonical EphA2 signaling is a driver of tumor-endothelial cell interactions and metastatic dissemination in BRAF inhibitor resistant melanoma.
202026 citationsauthor #6
Merkel Cell Carcinoma Outcomes: Does AJCC8 Underestimate Survival?
202035 citationsauthor #7
Effect of automated TIL quantification in early-stage melanoma on accuracy of standard T staging using AJCC guidelines.
20201 citationsauthor #16
Translational pathology, genomics and the development of systemic therapies for acral melanoma.
202045 citationsauthor #7
BRAF Targeting Sensitizes Resistant Melanoma to Cytotoxic T Cells
201928 citationsauthor #9
Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium.
2019196 citationsauthor #20
An erythematous facial rash.
20190 citationsauthor #3
A phase II, randomized study of nivolumab (NIVO) and Ipilimumab (IPI) versus NIVO, IPI and stereotactic body radiation therapy (SBRT) for metastatic Merkel cell carcinoma (MCC, NCT03071406): A preliminary report
20194 citationsauthor #13
Treg lymphocytes and cutaneous viral infections
20190 citationsauthor #4
Completion lymphadenectomy for a positive sentinel node biopsy in melanoma patients is not associated with a survival benefit
201915 citationsauthor #13
Management of intussusception in patients with melanoma
20199 citationsauthor #9
Phase I study of vemurafenib (VEM) and cobimetinib (COB) with heat shock protein 90 (HSP90) inhibitor XL888 in advanced BRAFV600 mutant melanoma.
20190 citationsauthor #9
Association Between Recent Ultraviolet Radiation Exposure and Cutaneous Beta Human Papillomavirus Infection
20190 citationsauthor #4
Melanocortin 1 Receptor–Targeted α-Particle Therapy for Metastatic Uveal Melanoma
201943 citationsauthor #9
Abstract 3800: HDAC8 regulates plasticity and escape from therapy in BRAF mutant melanoma
20190 citationsauthor #5
Performance of a 31‐gene expression profile test in cutaneous melanomas of the head and neck
201917 citationsauthor #3
Re-biopsy of partially sampled thin melanoma impacts sentinel lymph node sampling as well as surgical margins
20192 citationsauthor #10
Abstract PR13: PTPN11 plays oncogenic roles and is a therapeutic target for BRAF wild-type melanomas
201928 citationsauthor #5
HDAC8 Regulates a Stress Response Pathway in Melanoma to Mediate Escape from BRAF Inhibitor Therapy.
201960 citationsauthor #5
Perioperative Outcomes of Melanoma Patients Undergoing Surgery After Receiving Immunotherapy or Targeted Therapy
201913 citationsauthor #8
Pembrolizumab-associated tumor development in a patient with Sézary syndrome
20194 citationsauthor #4
Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma
201982 citationsauthor #8
Viruses in Skin Cancer (VIRUSCAN): Study Design and Baseline Characteristics of a Prospective Clinic-Based Cohort Study
20196 citationsauthor #7
The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy
2019134 citationsauthor #12
Recurrence of Melanoma After a Negative Sentinel Node Biopsy: Predictors and Impact of Recurrence Site on Survival
201936 citationsauthor #13
Abstract 2387: The oncogenic role and therapeutic potential of PTPN11 in melanoma
20180 citationsauthor #6
Interferon is associated with improved survival for node-positive cutaneous melanoma: a single-institution experience
20184 citationsauthor #7
Review of diagnostic, prognostic, and predictive biomarkers in melanoma
201835 citationsauthor #5
Guidelines of care for the management of cutaneous squamous cell carcinoma
20184 citationsauthor #10
Combined BRAF and HSP90 Inhibition in Patients with Unresectable BRAFV600E-Mutant Melanoma
201862 citationsauthor #18
Merkel Cell Carcinoma , Version 1 . 2018 Clinical Practice Guidelines in Oncology
20181 citationsauthor #30
Metastatic melanoma and prostatic adenocarcinoma in the same sentinel lymph node.
20184 citationsauthor #3
Behavior of Cutaneous Adnexal Malignancies: a Single Institution Experience
201811 citationsauthor #10
Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients
2018130 citationsauthor #18
Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.
2018253 citationsauthor #21
Abstract 4364: R-Ras activation cooperates with BRAF mutation in melanoma tumorigenesis
20180 citationsauthor #5
Female genitourinary tract melanoma: mutation analysis with clinicopathologic correlation a single-institution experience
201815 citationsauthor #8
Genomic analysis of a case of agminated Spitz nevi and congenital‐pattern nevi arising in extensive nevus spilus
201811 citationsauthor #6
Abstract 3025: Ligand-independent EphA2 signaling drives an amoeboid phenotype that promotes melanoma brain metastasis development
20181 citationsauthor #5
Microsatellitosis in Patients with Melanoma
201814 citationsauthor #11
Title Guidelines of care for the management of basal cell carcinoma Permalink
20180 citationsauthor #9
The Pathology of Melanoma
20180 citationsauthor #1
Pathologic analysis of melanocytic neoplasms.
20181 citationsauthor #1
Cutaneous Viral Infections Across 2 Anatomic Sites Among a Cohort of Patients Undergoing Skin Cancer Screening
20188 citationsauthor #5
Abstract A04: Cross-species oncogenomics approach identifies PTPN11 as an oncogene and potential therapeutic target in melanoma
20180 citationsauthor #7
Abstract B12: The importance of the RASA1/R-Ras/Ral-A signaling axis in melanoma tumorigenesis
20171 citationsauthor #5
Eczema Herpeticum: A Case Report and Review of Literature
20172 citationsauthor #4
Abstract 365: Cross-talk between BRAF and Hippo/YAP1 signaling in melanoma
20170 citationsauthor #4
Selecting Patients With Thin Melanoma for Sentinel Lymph Node Biopsy-This Time It's Personal.
20178 citationsauthor #2
Stratifying SLN incidence in intermediate thickness melanoma patients.
201731 citationsauthor #9

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT